Unchanged for decades, breast screening technology such as mammograms can be painful and generally rely on anatomical differences with several limitations.  These include the lack of phenotyping to identify aggressive tumors versus those that pose no mortality risk and the lack of contrast in dense breast tissue sometimes obstructing cancerous lumps from mammograms.  These limitations have led to an estimated $4 billion being overspent on … Continue reading Researchers use non-invasive ‘diagnostic pill’ to detect breast cancer in mice.